Moon Jae Hoon, Park Young Joo, Kim Tae Hui, Han Ji Won, Choi Sung Hee, Lim Soo, Park Do Joon, Kim Ki Woong, Jang Hak Chul
Department of Internal Medicine (J.H.M., S.H.C., S.L., H.C.J.) and Neuropsychiatry (T.H.K., J.W.H., K.W.K.), Seoul National University Bundang Hospital, Seoul National University College of Medicine, Seongnam 463-707, Korea; and Department of Internal Medicine (Y.J.P., D.J.P.), Seoul National University Hospital, Seoul National University College of Medicine, Seoul 110-799, Korea.
J Clin Endocrinol Metab. 2014 Feb;99(2):424-32. doi: 10.1210/jc.2013-3385. Epub 2013 Nov 27.
The association between subclinical hyperthyroidism and the risk of dementia has been validated in several studies. However, the effect of thyroid function within reference range on the risk of cognitive dysfunction including mild cognitive impairment (MCI) and dementia is still unclear.
Our aim was to investigate the association between thyroid function and the risk of MCI and dementia in euthyroid elderly subjects.
DESIGN, SETTING, AND PARTICIPANTS: We conducted a population-based prospective study as a part of the Korean Longitudinal Study on Health and Aging. A total of 313 participants who were euthyroid and nondemented at baseline and completed cognitive function tests at a 5-year follow-up evaluation (mean age 72.5 ± 6.9 y) were analyzed in the present study.
Baseline thyroid function was compared according to the development of MCI or dementia during the study period. Binary logistic regression analysis was performed to investigate the independent association between thyroid function and cognitive impairment.
At baseline evaluation, 237 subjects were cognitively normal, and 76 subjects had MCI. Diagnoses of cognitive function in 259 subjects remained unchanged or improved during the study period (nonprogression group), whereas 54 subjects showed progression of cognitive impairment to MCI or dementia (progression group). In the progression group, baseline serum TSH levels were lower than those in nonprogression group. Baseline serum free T₄ levels were not significantly different between these two groups. The association between lower baseline serum TSH levels and the development of MCI or dementia was maintained after adjustment for conventional baseline risk factors.
Lower serum TSH level within the reference range was independently associated with the risk of cognitive impairment including MCI and dementia in elderly subjects.
亚临床甲状腺功能亢进与痴呆风险之间的关联已在多项研究中得到验证。然而,甲状腺功能在参考范围内对包括轻度认知障碍(MCI)和痴呆在内的认知功能障碍风险的影响仍不明确。
我们的目的是研究甲状腺功能与甲状腺功能正常的老年受试者发生MCI和痴呆风险之间的关联。
设计、地点和参与者:作为韩国健康与老龄化纵向研究的一部分,我们进行了一项基于人群的前瞻性研究。本研究分析了313名在基线时甲状腺功能正常且无痴呆,并在5年随访评估中完成认知功能测试的参与者(平均年龄72.5±6.9岁)。
根据研究期间MCI或痴呆的发生情况比较基线甲状腺功能。进行二元逻辑回归分析以研究甲状腺功能与认知障碍之间的独立关联。
在基线评估时,237名受试者认知正常,76名受试者患有MCI。在研究期间,259名受试者的认知功能诊断保持不变或有所改善(非进展组),而54名受试者的认知障碍进展为MCI或痴呆(进展组)。进展组的基线血清促甲状腺激素(TSH)水平低于非进展组。两组之间的基线血清游离T₄水平无显著差异。在对传统基线风险因素进行调整后,较低的基线血清TSH水平与MCI或痴呆的发生之间的关联仍然存在。
在参考范围内较低的血清TSH水平与老年受试者包括MCI和痴呆在内的认知障碍风险独立相关。